A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China
Clinical trial NCT04015778 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04015778
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2026-05-30
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.